Enrolling trials is difficult, costly and competitive for industry sponsors. For study sites, trials are time-consuming and labor intensive, yet a way to be part of cutting edge research and resulting publication. For patients, clinical trials offer hope, access to the most current approaches to therapy, sometimes for diseases that have limited or no treatments. But what happens when study sites participate in multiple trials for the same disease population? How does competition for enrollment impact the
patient's decision to participate in a trial? How do PIs and clinical study staff educate patients about their options? And how do patients really perceive the medical professionals' role? Are decisions made without bias?

• Understand the perspective of principle investigators who conduct multiple trials to improve relationship strategies for future study sponsorships, and to compare the differences between rare and common disease areas
• Gain insight into the factors impacting the patient's decison-making process
• Explore the potential bioethical conflicts arising from competitive trials for same-disease populations and discuss recommendations to minimize these conflicts